With Congress divided, our U.S.-based team of analysts argues that regulators, not legislators, could do the most to influence the U.S. investment environment.
Family ties constitute a formidable force in both business and investing. Glen Finegan, Head of Global Emerging Market Equities, discusses the merits of family-owned firms as long-term investment opportunities within global emerging markets.
Learn how our Global Emerging Market Equities Team assesses sustainability in a holistic sense and understands that investment returns and environmental, social and governance concerns are not separate entities, but intertwined.
Global Life Sciences Co-Portfolio Manager Ethan Lovell discusses how faster, more accurate diagnoses followed by targeted therapies are transforming the way we tackle cancer treatment, leading to better clinical outcomes while reducing inefficiency in health care delivery.
Each month, the Adaptive Multi-Asset Solutions Team provides an asset class outlook using options market prices to infer expected tail gains and tail losses.